MicrobiologybioRxiv
Oral administration of S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and accelerates recovery from clinical aspects of COVID-19
M. Sasaki, K. Tabata, M. Kishimoto…·H. Sawa
This study shows that oral S-217622 reduces SARS-CoV-2 viral load and improves recovery in hamsters, with activity against multiple variants.
DOI 10.1126/scitranslmed.abq4064